For example, PKCα, PKCβ, PKCδ, and PKCε are targeted for treating cardiac hypertrophy, PKCβ, PKCδ, and PKCε are targeted for treating heart failure, and PKCθ for lowing heart transplant rejection [6,240,241]. The gene discussed is PRRT2; the disease is cardiac hypertrophy.